THE SCIENCE OF CANNABIS EXTRACTION,
THE SCIENCE BEHIND OUR SOLUTIONS
Radient's patented, proprietary continuous-flow extraction and processing technology is based on precise control of temperature and extraction time, both of which affect purity and extract profile. This careful control of extraction parameters is something that is nearly impossible to achieve at large scale with conventional methods. Our continuous-flow technology provides instant controlled heating of the biomass, creating a highly efficient extraction process that doesn’t rely on closed batch vessels. The result? A rapid-speed, temperature-controlled extraction that produces a purer, higher quality extract.
SPEED AND QUALITY, TOGETHER AT LAST
Our extraction method often eliminates additional steps required in most extraction methods, such as winterization, which typically adds at least a half day to the extraction process. Winterization can also eliminate desirous active compounds and lead to overall cannabinoid losses.
In addition, our continuous-flow process is designed so that we do not require that the cannabis biomass be decarboxylated prior to extraction. By decarboxylating downstream, we can maintain more of the volatile terpenes in the final extracts. As a result, we can often retain many of the active compounds found in the original plant.
WE CREATED THE TECHNOLOGY
THAT’S REINVENTING THE INDUSTRY
In 2018, Radient engaged a world-class intellectual property and innovation consulting firm to strategically protect and enhance our Intellectual Property. So far, Radient has filed more than 58 provisional patent applications with the United States Patent & Trademark Office (the “USPTO”) for technologies relating to:
- Methods, systems and apparatus for improving the efficiency, purity, quality, and yield of cannabis biomass extraction
- Methods and systems for improving the efficiency, accuracy, and security of supply chain tracking for extractable cannabis biomass
- Methods and systems for improving the safety, potency, flavour, and experience of cannabinoid extracts used in the manufacturing of food and beverage products
- Methods and systems for cannabinoid consumption products and devices
EDMONTON MANUFACTURING FACILITIES
Our Health Canada-approved Edmonton I facility is currently operational and can process 56,000 kg of cannabis/year.
Our Edmonton II facility, dedicated to the extraction and downstream processing of CBD from hemp, will be operational by the end of 2019. This facility will have a throughput capacity of more than 420,000 kg of hemp.
Our Edmonton III facility, which is currently under construction, will have a throughput capacity of 280,000 kg/year of cannabis, and 2.8 million kg/year of hemp. This facility will begin initial commissioning at the end of 2020, scaling up to full capacity thereafter.
GERMANY MANUFACTURING FACILITY
In order to meet growing demand for medical cannabis extracts and products in Europe, we are currently building our first European facility in Southern Germany, expected to begin initial commissioning at the end of 2020. When completed this facility will process 280,000 kg/year of cannabis, and more than 2.8 million kg/year of hemp.
RESEARCH & DEVELOPMENT LABORATORIES
Our primary Research & Development laboratory is located at the company’s main headquarters in Edmonton. In addition, we have contracted a second Research & Development laboratory and Pilot Plant based in Lyon, France, via Processium.